Side-by-side comparison of AI visibility scores, market position, and capabilities
FICO Score powers 90% of US lending decisions; $1.72B FY2024 revenue; 10-15% annual score price increases drive operating leverage; NYSE: FICO competes with VantageScore after 2023 FHFA ruling.
Fair Isaac Corporation (FICO) is the creator of the FICO Score—the dominant consumer credit score used in approximately 90% of U.S. lending decisions—and a provider of enterprise analytics and decision management software. Founded in 1956 by engineer Bill Fair and mathematician Earl Isaac in San Jose, California, FICO is now headquartered in Bozeman, Montana and trades on NYSE (FICO). The company reported approximately $1.72 billion in revenues for fiscal year 2024 (ending September 30) under CEO Will Lansing, split between two segments: Scores (FICO Score licensing to lenders and consumer credit bureau services) and Software (Falcon Platform for fraud detection, origination decision management, and customer engagement). FICO's stock has been one of the top-performing S&P 500 components over the past decade, compounding at over 30% annually as the company's pricing power and recurring revenue model became fully appreciated by investors.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.